2023

Collaboration as the Best Medicine – Part 2

by cyb2025

CLIVE BADMAN1, JAGJIT SINGH SRAI2
1. Director of Research in the Department of Engineering, University of Cambridge, and Head of Centre for International Manufacturing, Institute for Manufacturing, United Kingdom
2. Professor Clive Badman OBE FRSE
Executive Director, Business Engagement Group, University of Strathclyde

In Collaboration as the Best Medicine (1) published in Chemistry Today in 2019 we noted that after the highly successful ReMediES programme, collaborative work would continue through the newly approved Medicines Manufacturing Innovation Centre (MMIC) (2) located in Glasgow.

 

MMIC is a unique partnership providing companies of all sizes with a technologically advanced GMP-capable environment that they can use to develop a more agile, responsive, and sustainable medicines supply chain for the pharmaceutical industry through enhanced manufacturing processes.

 

ABOUT THE AUTHOR

Clive Badman took on a role in the Business Engagement Group at the University of Strathclyde, in October 2013, where he is a Professor of Practice. Concurrent to this role he was VP Pre-Competitive Activities, R&D, GSK where he worked for 40 years before retiring in July 2108. His expertise is in pharmaceutical manufacturing and supply chains, advanced manufacturing technologies and in the creation of impactful collaborations.
Clive was Industrial Chair for Continuous Manufacturing and Crystallisation (CMAC), an award winning academic/industry collaboration from 2011-2018 and he co- led the Remedies project from 2014-2018 representing 2 institutions and 21 industrial companies. Clive was awarded an OBE in 2012 for services to the Pharmaceutical industry and was elected a Fellow of the Royal Society of Edinburgh (FRSE) in 2021.

Dr Jagjit Singh Srai is Director of Research in the Department of Engineering and Head of the Centre for International Manufacturing, Institute for Manufacturing, University of Cambridge. He has Director/ Investigator roles across several major multi-disciplinary research projects (including Remedies, CMAC, Smart Pharma and DM2), bringing an engineering and strategic operations management perspective to the design, analysis and operation of international supply chains. Research projects explore the disruptive impacts of new production and digital technologies on supply chains, markets and regulation, and involve close collaborations with industry, academia, and public bodies.

Login